Intensive insulin therapy in critically ill patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Intensive insulin therapy in sepsis patients: Better data enables better intervention.Heliyon · 2023
   Review
2. Safety and efficacy of transitioning from intravenous to subcutaneous insulin in critically ill patients.International journal of clinical pharmacy · 2022
   Article
3. Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015
   Review
4. Intensive insulin therapy and mortality in critically ill patients.Critical care (London, England) · 2008
   Article

Corrections and comments

• Comment on
  Intensive insulin therapy in critically ill patients.2001
• Comment on
  Hemodynamic and metabolic therapy in critically ill patients.2001

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as